logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-11. Age at first use of primary drug among clients according to primary drug for which they enter treatment — EU summary of clients entering treatment, 2007 or most recent year available [see all tables in this series...]

Part (v) New inpatient clients, age at first use distribution by primary drug (%)

Substance<1515–1920–2425–2930–3435–3940–4445+Mean ageAge known (base)Age not known
Opiates5.542.528.712.75.72.31.41.222.13123162
Cocaine5.836.832.611.97.44.50.60.322.431035
Stimulants15.255.919.24.72.41.30.50.619.3114364
Hypnotics and sedatives8.922.414.49.89.86.48.020.231.1326114
Hallucinogens18.272.79.10.00.00.00.00.017.2111
Volatile substances59.134.43.82.20.50.00.00.015.618613
Cannabis 31.147.313.34.11.71.10.50.918.21326105
Other substances 7.527.418.917.05.76.66.610.427.710683
Total14.244.122.59.14.42.21.42.121.26531577

Notes:

 : indicates data not available 

 Countries reporting data: BG, CZ, DK, DE, IE, EL, FR, CY, LV, AT, RO, SK, FI, SE, HR, TR 

 The number of treatment clients in each country is listed in Table TDI-7

 See also Table TDI-108 on distribution by country and 'General notes for interpreting data’ on the Explanatory notes and help page

Sources:

 Reitox national reports 2008 — Table TDI — outpatient treatment centres. 

(see the help page for information about formats etc.)

Page last updated: Tuesday, 30 June 2009